Position in NVS
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,169,788
-$113,366 QoQ
Shares Held
13,845
-7.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#411
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HIGHLAND CAPITAL MANAGEMENT, LLC holds $74,462,523 across 8 Drug Manufacturers - General names. NVS ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
233,452 | $29,998,582 | |
| 2 | JNJ |
Johnson & Johnson
|
62,572 | $15,891,410 | |
| 3 | LLY |
ELI LILLY & Co
|
10,931 | $13,110,970 | |
| 4 | ABBV |
AbbVie Inc.
|
43,576 | $10,965,464 | |
| 5 | NVS |
Novartis AG
This page
|
13,845 | $2,169,788 | |
| 6 | GSK |
GSK plc
|
16,642 | $872,373 | |
| 7 | PFE |
Pfizer Inc
|
31,277 | $753,150 | |
| 8 | NVO |
Novo Nordisk A S
|
14,618 | $700,786 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,169,788 | 13,845 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,283,154 | 14,947 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,812,163 | 13,144 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,867,430 | 14,562 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $1,750,046 | 14,462 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,656,815 | 14,862 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $1,567,858 | 16,112 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,899,210 | 16,512 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $1,771,920 | 16,644 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,131,160 | 11,694 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,179,531 | 11,682 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $1,174,649 | 11,532 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,017,374 | 10,082 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $945,944 | 10,282 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $873,815 | 9,632 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $713,125 | 9,382 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $870,405 | 10,297 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $903,561 | 10,297 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $900,678 | 10,297 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $813,465 | 9,947 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $878,549 | 9,629 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $827,360 | 9,679 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $922,108 | 9,765 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $783,944 | 9,015 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $790,427 | 9,050 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $762,662 | 9,250 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||